Executive Summary
At the 2026 Future Food-Tech Summit, Amanda Davies (Chief R&D and Procurement Officer at Mars Snacking) laid bare an objective industry reality: "Scale remains the biggest hurdle, despite no shortage of great ideas."
When a global titan with tens of billions in proprietary manufacturing assets considers scale to be the ultimate bottleneck, mid-market FoodTech brands can no longer afford to treat manufacturing as a simple transactional vendor-selection task.
This briefing exposes the physical realities of the Execution Gap—how thermal shear, thermodynamic lag, and shared ecosystem vulnerabilities systematically compromise active ingredients during commercial scale-up. It outlines the Strategic Vendor Architecture (SVA) required to align formulation with the production reality.
The Physics of Failure
In the functional food and nutrition sector, there is a critical misconception that scaling is simply a linear translation of capacity. Physics, however, does not scale linearly alongside a pitch deck.
Consider Thermal Shear Degradation. In a 50L lab pilot, fluid dynamics are gentle and highly controlled. But when transitioning to a 50,000L commercial run, maintaining homogeneity requires the impellers of a commercial Stirred Tank Reactor (STR) to operate at elevated tip speeds. For sensitive bio-actives—such as advanced prebiotics, synbio proteins, or peptides—this intense mechanical shear, coupled with the immense pressure of UHT sterilization lines, systematically alters molecular structures.
Furthermore, labs execute precise instantaneous heating, whereas industrial UHT systems face immense thermodynamic resistance. The result is Thermodynamic Lag. A few extra seconds of uncontrolled residence time at peak temperature is enough to trigger phase separation, efficacy collapse, and organoleptic degradation...
